Fig. 1: Transplant outcomes of intermediate-risk AML adults with FLT3-wt in CR1 and uMRD: comparison between ASCT group and HAPLO group. | Bone Marrow Transplantation

Fig. 1: Transplant outcomes of intermediate-risk AML adults with FLT3-wt in CR1 and uMRD: comparison between ASCT group and HAPLO group.

From: Autologous stem cell transplantation in adult patients with intermediate-risk acute myeloid leukemia in first complete remission and no detectable minimal residual disease. A comparative retrospective study with haploidentical transplants of the global committee and the ALWP of the EBMT

Fig. 1: Transplant outcomes of intermediate-risk AML adults with FLT3-wt in CR1 and uMRD: comparison between ASCT group and HAPLO group.

a Relapse incidence (RI) b Non Relapse Mortality (NRM) c Leukemia Free Survival (LFS) d Overall Survival (OS) comparison between ASCT group and HAPLO group.

Back to article page